YES! Writing the COMPLETE notes for ALL topics right now. This is the full master document - same style as the 5-star answers, with flowcharts, tables, and Hindi mnemonics throughout.
🔥 COMPLETE BIOCHEMISTRY MASTER NOTES
One-Day Exam Preparation - All Topics
Same Style as ⭐⭐⭐⭐⭐ Questions
SECTION 1: CELL MEMBRANE
FLUID MOSAIC MODEL (Singer & Nicolson, 1972)
Key Concept: "Bilayer = Ocean, Proteins = Icebergs"
Structure:
OUTER LEAFLET
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
○○○ Peripheral protein ○○○
████████████████████████████████████ ← Phospholipid heads (hydrophilic)
|||||||| Integral protein ||||||||| ← Fatty acid tails (hydrophobic)
████████████████████████████████████ ← Phospholipid heads
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
INNER LEAFLET
Components:
| Component | Type | Function |
|---|
| Phospholipid bilayer | Fluid | Structural backbone |
| Integral proteins | Span full bilayer | Channels, transporters, receptors |
| Peripheral proteins | Surface only | Signaling, structural support |
| Cholesterol | Intercalated | Regulates fluidity (stabilizer) |
| Glycoproteins/Glycolipids | Outer leaflet | Cell recognition, ABO blood groups |
Membrane Fluidity Factors:
- Increases fluidity: ↑ Temperature, ↑ Unsaturated FA (kinks prevent packing), ↓ Cholesterol (at low temp)
- Decreases fluidity: ↓ Temperature, ↑ Saturated FA, ↑ Cholesterol (at high temp = stabilizer)
Hindi Mnemonic: "MANIK ka MEMBRANE - Fluid jaise PANI"
Mosaic = M, Fluid = F, Bilayer = B → MFB = Manik Full Bada (Singer-Nicolson model)
TRANSPORT ACROSS CELL MEMBRANE
PASSIVE (No ATP) ACTIVE (ATP required)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Simple diffusion │ Facilitated │ Primary │ Secondary
O₂, CO₂, N₂, │ diffusion │ Na⁺/K⁺- │ SGLT1
ethanol, steroids │ GLUT1-4 │ ATPase │ (Na⁺-Glucose
(small nonpolar) │ (glucose, │ Ca²⁺-ATPase │ cotransport)
│ fructose) │ H⁺/K⁺-ATPase│
│ Ion channels │ │
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
ENDOCYTOSIS (in) EXOCYTOSIS (out)
Phagocytosis (cells) Secretion of hormones
Pinocytosis (fluid) Neurotransmitters
Receptor-mediated Mucus secretion
(LDL, insulin)
GLUT Transporters (Exam Favourite!):
| GLUT | Location | Km | Regulation |
|---|
| GLUT-1 | RBC, brain, placenta | Low | Constitutive (always active) |
| GLUT-2 | Liver, pancreatic β-cell, kidney | High | Glucose sensor (not saturated) |
| GLUT-3 | Neurons | Very low | Constitutive |
| GLUT-4 | Muscle, adipose | Low | Insulin-dependent ← Key! |
| GLUT-5 | Small intestine | - | Fructose transporter |
Mnemonic: "RADHIKA BGLNA" - Brain/RBC=GLUT1, Glucose sensor=GLUT2, Liver/Neuron=GLUT3, Nudge by insulin=GLUT4, Absorption of fructose=GLUT5
SECTION 2: ENZYMES
CLASSIFICATION (EC Numbers)
Master Mnemonic: "OTHLI L" = "RISHIKA ONLY THINKS HAVING LOVELY INTELLIGENT LOOKS"
| No. | Class | Reaction | Example |
|---|
| 1 | Oxidoreductases | Oxidation-reduction | LDH, G6PD, Cytochrome oxidase |
| 2 | Transferases | Transfer functional groups | Aminotransferases (ALT, AST), Kinases |
| 3 | Hydrolases | Hydrolysis | Proteases, Lipases, Phosphatases |
| 4 | Lyases | Add/remove without hydrolysis | Aldolase, Decarboxylases |
| 5 | Isomerases | Structural rearrangements | Phosphoglucoisomerase, Mutases |
| 6 | Ligases (Synthetases) | Join + ATP | Acetyl-CoA synthetase, Amino acyl-tRNA synthetase |
MECHANISM OF ENZYME ACTION
Two Key Theories:
1. Lock and Key Theory (Fischer, 1894)
- Enzyme active site = rigid lock
- Substrate = specific key
- NO conformational change
2. Induced Fit Theory (Koshland, 1958) - ACCEPTED
- Active site changes shape to fit substrate
- Enzyme molds around substrate
- More accurate - explains broad substrate specificity
Catalytic Mechanisms:
Enzyme + Substrate → [ES Complex] → Enzyme + Product
↑
TRANSITION STATE
(lower activation energy)
Ways enzymes lower activation energy:
- Proximity & orientation - brings substrates close
- Acid-Base catalysis - H⁺ donation/acceptance (His residue)
- Covalent catalysis - transient ES covalent bond (Ser proteases)
- Metal ion catalysis - stabilize transition state (Zn²⁺ in carboxypeptidase)
- Strain distortion - distorts substrate bonds
Mnemonic: "DIVYA PASSES Chemistry" = Proximity, Acid-base, Strain, Covalent, Electrostatic = enzyme mechanisms
ENZYME KINETICS (Michaelis-Menten)
Vmax × [S]
V = ───────────
Km + [S]
Km = substrate concentration at ½ Vmax
= measure of enzyme-substrate AFFINITY
= LOW Km → HIGH affinity
= HIGH Km → LOW affinity
Vmax = maximum velocity (all active sites occupied)
Lineweaver-Burk Plot (Double Reciprocal):
1/V
| competitive inhibitor
| /
| / no inhibitor
| / /
| / / non-competitive inhibitor
| / / /
|___/___/__/______________ 1/[S]
-1/Km 0
ENZYME INHIBITION
Competitive vs Non-Competitive
| Feature | Competitive | Non-Competitive |
|---|
| Binding site | Active site | Allosteric site |
| Structural similarity to substrate | YES | No |
| Effect on Km | ↑ Km (↓ affinity) | No change |
| Effect on Vmax | No change | ↓ Vmax |
| Can substrate overcome? | YES (high [S]) | NO |
| Lineweaver-Burk | X-intercept changes, same Y | Y-intercept changes, same X |
| Examples | Methotrexate vs DHFR; Statins vs HMG-CoA reductase; Sulfonamides vs PABA | Cyanide vs cytochrome oxidase; Heavy metals |
Hindi Mnemonic:
"SHUBHAM COMPETES - Km badha deta hai" = Competitive → Km increases
"NAMANYA NON-competitive - Vmax gira deti hai" = Non-competitive → Vmax decreases
Irreversible Inhibition:
- Covalently binds enzyme - permanent block
- Examples: Aspirin (COX), Organophosphates (AChE), Penicillin (transpeptidase)
- Requires new enzyme synthesis to recover
Uncompetitive Inhibition:
- Binds ONLY to ES complex (not free enzyme)
- Both Km AND Vmax decrease (parallel lines on Lineweaver-Burk)
ISOENZYMES (Short Note)
- Definition: Multiple forms of same enzyme - same function, different structure/electrophoretic mobility/organ distribution
- Clinical use: Organ-specific damage marker
| Isoenzyme | Subunits | Location | Rise in AMI | Clinical Use |
|---|
| LDH-1 (H₄) | 4H | Heart, RBC | 12-24h | MI, hemolysis |
| LDH-2 (H₃M) | 3H,1M | Heart | - | - |
| LDH-3 (H₂M₂) | 2H,2M | Lung, spleen | - | - |
| LDH-4 (HM₃) | 1H,3M | Kidney, placenta | - | - |
| LDH-5 (M₄) | 4M | Liver, skeletal muscle | - | Liver disease |
| CK-MB | M+B | Heart | Peaks 24h | Gold standard AMI |
| CK-MM | M+M | Skeletal muscle | - | Rhabdomyolysis |
| CK-BB | B+B | Brain | - | Limited clinical use |
| ALP (bone) | - | Osteoblasts | - | Paget's, rickets |
| ALP (liver) | - | Bile canaliculi | - | Cholestasis |
"LDH-1 > LDH-2 = Heart attack" (normally LDH-2 > LDH-1 = FLIP pattern in MI)
Mnemonic: "MANIK's HEART FLIPS in MI"
COENZYMES (Short Note)
| Coenzyme | Vitamin | Reaction Type | Enzyme |
|---|
| NAD⁺/NADH | B3 (Niacin) | Oxidoreduction (H transfer) | LDH, malate DH |
| NADP⁺/NADPH | B3 (Niacin) | Reductive biosynthesis | G6PD, FA synthase |
| FAD/FADH₂ | B2 (Riboflavin) | Oxidoreduction | Succinate DH, Acyl-CoA DH |
| CoA/Acetyl-CoA | B5 (Pantothenate) | Acyl group transfer | Pyruvate DH, Citrate synthase |
| TPP | B1 (Thiamine) | Oxidative decarboxylation | Pyruvate DH, α-KG DH, Transketolase |
| PLP | B6 (Pyridoxine) | Transamination, decarboxylation | ALT, AST, ALA synthase |
| Biotin | B7 | CO₂ fixation (carboxylation) | Acetyl-CoA carboxylase, Pyruvate carboxylase |
| THF | B9 (Folate) | 1-carbon transfer | Thymidylate synthase |
| B12 (Cobalamin) | B12 | Methyl group transfer | Methionine synthase, Methylmalonyl-CoA mutase |
| Lipoic acid | - | Acyl group transfer | Pyruvate DH complex |
Mnemonic: "RADHIKA's VITAMINS Never Fail"
B1=TPP, B2=FAD, B3=NAD, B5=CoA, B6=PLP, B7=Biotin, B9=THF, B12=B12
DIAGNOSTIC IMPORTANCE OF ENZYMES
| Enzyme | Disease | Pattern |
|---|
| AST, ALT | Liver disease | ALT > AST = viral hepatitis; AST:ALT >2:1 = alcoholic |
| ALP | Cholestasis, Paget's | ↑↑ with GGT = liver; ↑↑ without GGT = bone |
| GGT | Alcoholic liver disease | Most sensitive marker of alcohol |
| LDH | MI, hemolysis, malignancy | LDH-1 > LDH-2 = MI "flip" |
| CK-MB | Acute MI | Rises 4-6h, peaks 24h, normal by 48-72h |
| Troponin I/T | MI | Most specific cardiac marker! |
| Amylase | Pancreatitis | Rises within hours, brief elevation |
| Lipase | Pancreatitis | More specific; stays elevated longer |
| Acid phosphatase | Prostate cancer | PSA replaced it |
| Cholinesterase | Organophosphate poisoning | ↓ activity |
Mnemonic: "DIVYA CALLS AMBULANCE" = Diagnostic enzymes for emergency conditions
SECTION 3: CARBOHYDRATE CHEMISTRY & METABOLISM
GLYCOSAMINOGLYCANS (GAGs)
Definition: Long, unbranched, negatively charged heteropolysaccharides made of REPEATING DISACCHARIDE units
Structure: N-acetylated amino sugar + Acidic sugar (repeating)
- N-acetyl amino sugar = GlcNAc or GalNAc
- Acidic sugar = Glucuronic acid or Iduronic acid (give negative charge)
- Heavily sulfated → strongly ANIONIC → attract water → gel consistency
Types of GAGs:
| GAG | Sulfated? | Protein Core | Location | Clinical |
|---|
| Hyaluronic acid | NO | NO (free) | Vitreous humor, synovial fluid, skin | Lubricant |
| Chondroitin sulfate | YES | YES | Cartilage, bone, cornea | - |
| Dermatan sulfate | YES | YES | Skin, heart valves, blood vessels | - |
| Heparan sulfate | YES | YES | Basement membrane, cell surfaces | Anticoagulant |
| Heparin | YES (most) | YES | Mast cells | Anticoagulant (clinical) |
| Keratan sulfate | YES | YES | Cornea, bone (NO uronic acid!) | - |
Mnemonic: "SHUBHAM's HC DKH" = Hyaluronic, Chondroitin, Dermatan, Keratan, Heparan, Heparin
MUCOPOLYSACCHARIDOSES (Lysosomal Storage Diseases):
| Disease | Deficient Enzyme | Accumulated GAG | Features |
|---|
| Hurler (MPS I) | α-L-Iduronidase | Heparan + Dermatan sulfate | Gargoylism, corneal clouding, mental retardation |
| Hunter (MPS II) | Iduronate sulfatase | Heparan + Dermatan sulfate | X-linked, NO corneal clouding |
| Sanfilippo (MPS III) | Various | Heparan sulfate | Severe mental retardation |
| Morquio (MPS IV) | Galactosamine-sulfatase | Keratan sulfate | Skeletal dysplasia, normal intelligence |
Mnemonic: "HURLER has HORNS (corneal clouding), HUNTER HUNTS without glasses (no corneal)"
HOMOPOLYSACCHARIDES
Definition: Polysaccharides made of SAME type of monosaccharide units
| Name | Monomer | Linkage | Function | Location |
|---|
| Starch | Glucose | α-1,4 (amylose); α-1,4 + α-1,6 (amylopectin) | Energy storage | Plants |
| Glycogen | Glucose | α-1,4 main chain; α-1,6 at branches | Energy storage | Liver (10%), Muscle (2%) |
| Cellulose | Glucose | β-1,4 | Structural (plants) | Plants (humans cannot digest) |
| Chitin | GlcNAc | β-1,4 | Structural | Insect exoskeleton, fungi |
| Dextran | Glucose | α-1,6 main; α-1,3 branches | Plasma expander | Bacteria |
| Inulin | Fructose | β-2,1 | GFR marker (not metabolized) | Plants |
Key fact: Glycogen vs Starch:
- Glycogen = MORE branched (branch every 8-10 residues)
- Amylopectin = branch every 24-30 residues
- More branches = faster glucose release = better for rapid energy
Mnemonic: "MANIK STACKS GREAT CELLULOSE" = Starch, Glycogen, Cellulose = 3 main homopolysaccharides
GLYCOLYSIS (LAQ)
Location: Cytoplasm | Net yield (aerobic): 2 ATP, 2 NADH, 2 Pyruvate
Complete Flowchart:
GLUCOSE (C6)
│ [1] Hexokinase / Glucokinase ← ATP used (-1 ATP)
│ Irreversible
▼
Glucose-6-Phosphate
│ [2] Phosphoglucoisomerase
▼
Fructose-6-Phosphate
│ [3] PHOSPHOFRUCTOKINASE-1 (PFK-1) ← ATP used (-1 ATP)
│ *** RATE-LIMITING STEP ***
│ Activated: AMP, F-2,6-BP, insulin
│ Inhibited: ATP, citrate, glucagon
▼
Fructose-1,6-Bisphosphate
│ [4] Aldolase
▼
Dihydroxyacetone-P + Glyceraldehyde-3-P (DHAP ⇌ G3P)
│ [5] Triosephosphate isomerase
▼
2× Glyceraldehyde-3-Phosphate
│ [6] GAPDH (NAD⁺→NADH) ← NAD⁺ required!
▼
2× 1,3-Bisphosphoglycerate
│ [7] Phosphoglycerate kinase → +2 ATP (×2 = +4 ATP)
│ [SUBSTRATE-LEVEL PHOSPHORYLATION]
▼
2× 3-Phosphoglycerate
│ [8] Phosphoglycerate mutase
▼
2× 2-Phosphoglycerate
│ [9] Enolase (inhibited by Fluoride!)
▼
2× Phosphoenolpyruvate (PEP)
│ [10] PYRUVATE KINASE → +2 ATP (×2 = +4 ATP)
│ Irreversible | Activated: F-1,6-BP | Inhibited: ATP, Alanine
▼
2× PYRUVATE
NET: -2 ATP + 4 ATP = +2 ATP
2 NADH (used in ETC = +5 ATP aerobically)
3 IRREVERSIBLE STEPS (bypassed in Gluconeogenesis):
GLYCOLYSIS GLUCONEOGENESIS BYPASS
Hexokinase → Glucose-6-phosphatase (liver/kidney only!)
PFK-1 → Fructose-1,6-bisphosphatase
Pyruvate kinase → Pyruvate carboxylase + PEPCK
Mnemonic: "NAMANYA HPP bypass krti hai" = Hexokinase, PFK-1, Pyruvate kinase = the 3 irreversible ones
GLUCONEOGENESIS
Definition: Synthesis of glucose from non-carbohydrate precursors
Location: Liver (90%), Kidney (10%)
Occurs during: Fasting, starvation, prolonged exercise
Gluconeogenic Precursors (LAMP Mnemonic):
- L - Lactate (from muscle, RBC via Cori cycle)
- A - Amino acids (glucogenic: Ala, Glu, Asp etc.) - especially ALANINE
- M - "M" glycerol (from triglyceride breakdown in adipose)
- P - Propionate (odd-chain FA → succinyl-CoA → OAA)
Hindi Mnemonic: "DIVYA ke LAMP se Glucose bana" = Lactate, Alanine, glycerol (M), Propionate
Key Unique Enzymes:
| Enzyme | Location | Role |
|---|
| Pyruvate carboxylase | Mitochondria | Pyruvate → OAA (needs biotin, acetyl-CoA) |
| PEPCK | Cytoplasm | OAA → PEP (needs GTP) |
| Fructose-1,6-bisphosphatase | Cytoplasm | F-1,6-BP → F-6-P (inhibited by AMP, F-2,6-BP) |
| Glucose-6-phosphatase | ER membrane | G-6-P → Glucose (ONLY liver & kidney!) |
Cori Cycle:
MUSCLE: LIVER:
Glucose → Lactate →→→→→ Lactate → Glucose
(anaerobic glycolysis) (gluconeogenesis)
←←←←←←←←←←←←←←
Blood
Cost: 2 ATP in muscle, 6 ATP in liver
Mnemonic: "SHUBHAM goes CORI way - Muscle deta hai, Liver lata hai"
GLYCOGEN METABOLISM & ITS REGULATION (LAQ)
GLYCOGEN SYNTHESIS:
Glucose → G-6-P → G-1-P
↓ UTP + Glucose-1-P
UDP-Glucose [UDP-glucose pyrophosphorylase]
↓
Added to glycogen chain [Glycogen synthase] ← KEY ENZYME
↓ (when chain >11 residues)
Branching enzyme (α-1,4 → α-1,6 bonds every 8-10 residues)
GLYCOGENOLYSIS (Breakdown):
Glycogen
↓ [Glycogen phosphorylase] ← RATE-LIMITING
(requires Vit B6/PLP as cofactor!)
G-1-P → G-6-P → Glucose (via G-6-Phosphatase in LIVER)
→ Stays in muscle (no G-6-Phosphatase in MUSCLE)
Debranching enzyme:
- Transfers 3 of 4 residues at branch → new chain (transferase activity)
- Cleaves last residue at α-1,6 bond → free glucose (glucosidase activity)
REGULATION (Most Important!):
GLUCAGON/EPINEPHRINE (fasting/stress)
↓
↑ cAMP → Protein Kinase A (PKA)
↓
Phosphorylates:
┌──────────────────────┐
│ Glycogen PHOSPHORYLASE b → a (ACTIVE) ↑ GLYCOGENOLYSIS
│ Glycogen SYNTHASE I → D (INACTIVE) ↓ SYNTHESIS
└──────────────────────┘
INSULIN (fed state)
↓
Activates Protein Phosphatase
↓
Dephosphorylates:
┌──────────────────────┐
│ Glycogen PHOSPHORYLASE a → b (INACTIVE) ↓ GLYCOGENOLYSIS
│ Glycogen SYNTHASE D → I (ACTIVE) ↑ SYNTHESIS
└──────────────────────┘
KEY RULE: "Phosphorylation ACTIVATES phosphorylase but INACTIVATES synthase"
Mnemonic: "RADHIKA's PHOSPHO rule: Phospho = Phoda (breaks) glycogen"
Glycogen Storage Diseases:
| Disease | Enzyme Defect | Organ | Feature |
|---|
| Von Gierke (Type I) | G-6-Phosphatase | Liver, Kidney | Severe fasting hypoglycemia, hepatomegaly |
| Pompe (Type II) | Lysosomal α-1,4-glucosidase (Acid maltase) | Generalized | Cardiomegaly, muscle weakness, death in infancy |
| Cori (Type III) | Debranching enzyme | Liver, Muscle | Mild hypoglycemia |
| Anderson (Type IV) | Branching enzyme | Liver | Cirrhosis |
| McArdle (Type V) | Muscle phosphorylase | Muscle | Painful cramps on exercise, no lactate rise |
| Hers (Type VI) | Liver phosphorylase | Liver | Mild symptoms |
Mnemonic: "VERY POOR CARB DIET MAKES HEALTH BAD" = Von Gierke, Pompe, Cori, Anderson, McArdle, Hers
HMP SHUNT (Pentose Phosphate Pathway) - Short Note
Location: Cytoplasm | No ATP generated
Active tissues: Liver, adrenal cortex, RBC, mammary gland, gonads, lens
Two Phases:
OXIDATIVE PHASE (irreversible):
Glucose-6-P
↓ [G6PD] ← RATE-LIMITING (needs NADP⁺)
6-Phosphogluconolactone + NADPH
↓ [6-Phosphogluconate dehydrogenase]
Ribulose-5-P + CO₂ + NADPH
(2 NADPH produced per cycle)
NON-OXIDATIVE PHASE (reversible):
Ribulose-5-P ⇌ Ribose-5-P (via isomerase)
Transketolase + Transaldolase shuffle carbons
→ F-6-P and G-3-P (re-enter glycolysis)
Products & Their Uses:
| Product | Used for |
|---|
| NADPH | FA synthesis, cholesterol synthesis, glutathione reduction, cytochrome P450, RBC antioxidant defense |
| Ribose-5-P | Nucleotide synthesis (DNA/RNA) |
| CO₂ | Released |
Mnemonic: "SHUBHAM's HMP = NADPH for Nailing Defense"
GALACTOSE METABOLISM - Short Note
Dietary Lactose
↓ [Lactase]
Glucose + GALACTOSE
↓ [Galactokinase] ← uses ATP
Galactose-1-Phosphate
↓ [Galactose-1-P Uridyltransferase (GALT)] ← KEY ENZYME
+ UDP-Glucose
Glucose-1-P + UDP-Galactose
↓ [UDP-Galactose-4-epimerase]
UDP-Glucose (recycled)
↓
Glucose-1-P → Glycolysis
Galactosemia Types:
| Type | Enzyme Defect | Accumulates | Features |
|---|
| Classic (Type I) | GALT (Transferase) | Gal-1-P | Jaundice, cataracts, liver damage, E. coli sepsis, intellectual disability |
| Type II (Galactokinase deficiency) | Galactokinase | Galactose → Galactitol | Only CATARACTS (galactitol accumulates in lens) |
| Type III | Epimerase | Mild | Usually benign |
Treatment: Eliminate galactose and lactose from diet
Mnemonic: "DIVYA GALT problem = JAUNDICE + CATARACTS + E. coli"
SECTION 4: LIPID CHEMISTRY & METABOLISM
PHOSPHOLIPIDS
Structure:
Polar head group (choline/ethanolamine/serine/inositol)
|
┌────┴────┐
│ GLYCEROL │
└─┬──┬──┬─┘
│ │ │
FA FA Phosphate-head
(sn-1)(sn-2)(sn-3)
sn-2 position usually = UNSATURATED fatty acid (arachidonic acid source!)
Major Types:
| Phospholipid | Head Group | Location/Function |
|---|
| Phosphatidylcholine (Lecithin) | Choline | Most abundant; lung SURFACTANT (L/S ratio) |
| Phosphatidylethanolamine (Cephalin) | Ethanolamine | Brain, clotting |
| Phosphatidylserine | Serine | Brain; flip to outer leaflet in apoptosis |
| Phosphatidylinositol (PI) | Inositol | Signal transduction (IP₃/DAG) |
| Cardiolipin | Two phosphates | Inner mitochondrial membrane; target in antiphospholipid syndrome |
| Sphingomyelin | Phosphocholine + Sphingosine | Myelin sheath (NOT glycerol backbone!) |
| Plasmalogen | Ether-linked FA | Heart, myelin |
Lung maturity = L/S ratio >2.0 (Lecithin:Sphingomyelin)
Mnemonic: "SHUBHAM's LUNG = L/S 2 se zyada = Safe delivery"
GLYCOSPHINGOLIPIDS
Backbone: Sphingosine (not glycerol!)
Structure: Ceramide (sphingosine + FA) + Sugar residues
| Type | Sugar | Location | Deficient Enzyme in Disease |
|---|
| Cerebroside | Glucose or Galactose | Brain, RBC membrane | |
| Galactocerebroside | Galactose | Myelin | β-Galactocerebrosidase → Krabbe disease |
| Glucocerebroside | Glucose | RES cells | β-Glucocerebrosidase → Gaucher disease |
| Sulfatide | Galactose sulfate | Myelin | Arylsulfatase A → Metachromatic leukodystrophy |
| Gangliosides (GM1,GM2) | Multiple + Sialic acid | Brain synapse | Hexosaminidase A → Tay-Sachs (GM2) |
| Globoside | Multiple | RBC, kidney | |
Mnemonic: "RADHIKA GETS TIRED" = Gaucher, Krabbe, Tay-Sachs = storage diseases
Key Storage Diseases:
| Disease | Enzyme | Accumulates | Feature |
|---|
| Gaucher | β-Glucocerebrosidase | Glucocerebroside | Gaucher cells (crumpled paper); hepatosplenomegaly; most common LSD |
| Niemann-Pick | Sphingomyelinase | Sphingomyelin | Cherry red spot, foam cells; neurodegeneration |
| Tay-Sachs | Hexosaminidase A | GM2 ganglioside | Cherry red spot, no hepatosplenomegaly; Jewish population |
| Krabbe | Galactocerebrosidase | Galactocerebroside | Globoid cells; severe neurodegeneration |
| Fabry | α-Galactosidase A | Ceramide trihexoside | X-linked; angiokeratomas, renal failure |
Mnemonic: "NAMANYA GETS NEW FABRICS = Niemann, Gaucher, Tay-sachs, Krabbe, Fabry"
FATTY ACID SYNTHESIS
Location: CYTOPLASM | Liver >> adipose > lactating mammary gland
Requires: NADPH (from HMP shunt/malic enzyme) + ATP + Biotin
Key Steps:
STEP 1: Acetyl-CoA escapes mitochondria as CITRATE
Acetyl-CoA + OAA → Citrate (in mito)
Citrate → cytoplasm → ATP citrate lyase → Acetyl-CoA + OAA
STEP 2: ACETYL-CoA CARBOXYLASE (ACC) ← RATE-LIMITING STEP
Acetyl-CoA + CO₂ + ATP + BIOTIN → MALONYL-CoA
Activated by: Citrate, Insulin
Inhibited by: Palmitoyl-CoA (product), Glucagon, AMPK
STEP 3: Fatty Acid Synthase (FAS) - 7 reactions repeat
Starting: 1 Acetyl-CoA + 7 Malonyl-CoA
Each cycle: adds 2C to chain
→ PALMITATE (C16) as final product
FA Synthesis vs Beta Oxidation (Comparison Table - Exam Favourite!):
| Feature | FA SYNTHESIS | BETA OXIDATION |
|---|
| Location | Cytoplasm | Mitochondria |
| Carrier | ACP (Acyl carrier protein) | CoA |
| Cofactor | NADPH (reductive) | FAD, NAD⁺ (oxidative) |
| Activated by | Insulin, Citrate | Glucagon, Epinephrine |
| Inhibited by | Glucagon, Malonyl-CoA (!) | Malonyl-CoA inhibits CPT-I |
| Shuttle | Citrate shuttle (acetyl-CoA out) | Carnitine shuttle (FA in) |
| Rate-limiting | Acetyl-CoA carboxylase | CPT-I |
Mnemonic: "DIVYA SYNTHESIZES in CYTOPLASM, BURNS in MITOCHONDRIA"
CHOLESTEROL METABOLISM
Synthesis (HMG-CoA Pathway):
Acetyl-CoA + Acetyl-CoA
↓ [Thiolase]
Acetoacetyl-CoA
↓ [HMG-CoA synthase] (cytoplasm - different from mito for ketones!)
HMG-CoA (3-Hydroxy-3-methylglutaryl-CoA)
↓ [HMG-CoA REDUCTASE] ← RATE-LIMITING STEP ← Statin target!
Mevalonate
↓ (several steps)
Squalene → Lanosterol → CHOLESTEROL
Regulation of HMG-CoA Reductase:
- Activated/expressed more: Low cholesterol, Insulin
- Inhibited/degraded: High cholesterol (SREBP-2 pathway), Glucagon, Statins
- Phosphorylated (inactive) by AMPK when energy low
- Dephosphorylated (active) by insulin
Cholesterol Functions:
- Membrane fluidity regulator
- Precursor: Bile acids, Steroid hormones (cortisol, sex hormones), Vitamin D
- Carried in blood by lipoproteins
Cholesterol Transport:
LIVER → VLDL → IDL → LDL → Peripheral tissues
↑
LDL receptor (ApoB-100 recognized)
Defective in FAMILIAL HYPERCHOLESTEROLEMIA
Reverse Cholesterol Transport:
Peripheral tissues → HDL → Liver (via CETP)
ApoA-I activates LCAT (converts free cholesterol → cholesteryl ester)
Mnemonic: "MANIK's STATIN stops HMG-CoA Reductase = Lower cholesterol"
LIPOTROPIC FACTORS & FATTY LIVER - Short Note
Lipotropic Factors = Substances that PREVENT fat accumulation in liver
| Factor | How it prevents fatty liver |
|---|
| Choline | Needed for VLDL synthesis (phosphatidylcholine) → exports fat from liver |
| Methionine | Provides methyl groups for choline synthesis; S-adenosylmethionine (SAM) donor |
| Inositol | Component of phosphatidylinositol |
| Betaine | Methyl donor for choline synthesis |
| Vitamin B12, Folate | Methyl group metabolism |
| Essential FA | Needed for phospholipid synthesis |
Fatty Liver (Hepatic Steatosis):
Causes (when lipotropic factors deficient or overwhelmed):
- Excess alcohol → ↑ NADH → ↓ FA oxidation + ↑ FA synthesis → fat accumulates
- Protein malnutrition (Kwashiorkor) → ↓ Choline/Apo-B → VLDL export fails
- Obesity, diabetes, NASH
- CCl₄ poisoning → damages ER → blocks VLDL export
Mnemonic: "SHUBHAM's CHOLINE saves his LIVER from FAT - Choline + Methionine = Lipotrohic team"
SECTION 5: PROTEIN CHEMISTRY & METABOLISM
PLASMA PROTEINS
Synthesized mainly in: LIVER (except immunoglobulins = plasma cells; von Willebrand = endothelium)
Normal Values & Functions:
| Protein | Normal | Function | Change in Disease |
|---|
| Albumin | 3.5-5.0 g/dL | Oncotic pressure, transport (bilirubin, drugs, Ca²⁺, FA) | ↓ Liver disease, malnutrition, nephrotic syndrome |
| α₁-Antitrypsin | - | Inhibits elastase in lungs | Deficiency → emphysema, liver cirrhosis |
| α₂-Macroglobulin | - | Protease inhibitor | ↑ In nephrotic syndrome |
| Haptoglobin | - | Binds free Hb | ↓ In hemolysis |
| Transferrin | - | Iron transport | ↑ TIBC in iron deficiency |
| Ceruloplasmin | - | Copper transport, ferroxidase | ↓ Wilson's disease |
| Fibrinogen | - | Clotting (Factor I) | ↑ In inflammation (acute phase) |
| CRP | <1 mg/L | Acute phase reactant | ↑ Infection, inflammation |
| Immunoglobulins | - | Antibodies | ↑ Multiple myeloma (M band) |
| Prealbumin (Transthyretin) | - | Thyroxine + retinol transport | Best marker of nutritional status |
Acute Phase Proteins:
- Positive (increase): CRP, Fibrinogen, Haptoglobin, Ferritin, α₁-Antitrypsin, Ceruloplasmin
- Negative (decrease): Albumin, Transferrin, Prealbumin
Mnemonic: "RADHIKA's CRP FIERCELY rises" = CRP, Fibrinogen, Inflammation markers rise in acute phase
AMINO ACID CLASSIFICATION
By Nutritional Requirement:
Essential (cannot synthesize - must eat): PVT TIM HaLL
- Phenylalanine, Valine, Threonine, Tryptophan, Isoleucine, Methionine, Histidine, a-Arginine (semi), Lysine, Leucine
Conditionally Essential: Arginine, Glutamine, Glycine, Cysteine, Tyrosine, Proline
By R-group (Side chain):
| Class | Amino Acids |
|---|
| Non-polar (hydrophobic) | Gly, Ala, Val, Leu, Ile, Pro, Phe, Trp, Met |
| Polar uncharged | Ser, Thr, Cys, Tyr, Asn, Gln |
| Positively charged (basic) | Lys, Arg, His (at pH 7) |
| Negatively charged (acidic) | Asp, Glu |
| Branched chain (BCAA) | Val, Leu, Ile (metabolized in MUSCLE!) |
| Aromatic | Phe, Tyr, Trp |
| Sulfur-containing | Cys, Met |
| Glucogenic | Most amino acids |
| Ketogenic only | Leu, Lys |
| Both | Phe, Tyr, Trp, Ile, Thr |
Mnemonic: "LILLY is Ketogenic" = Leucine + Lysine = ONLY ketogenic AAs
STRUCTURAL CLASSIFICATION OF PROTEINS
| Level | Bonds | Example |
|---|
| Primary | Peptide bonds (covalent) | Amino acid sequence |
| Secondary | Hydrogen bonds | α-helix, β-pleated sheet |
| Tertiary | H-bonds, ionic, disulfide, hydrophobic | 3D folding of single chain |
| Quaternary | Same as tertiary (between subunits) | Hemoglobin (2α+2β) |
Special Structures:
- α-helix: Right-handed; 3.6 residues/turn; proline BREAKS helix
- β-sheet: Parallel or antiparallel; H-bonds between strands
- Triple helix: Collagen (Gly-Pro-Hydroxyproline repeat; Vit C needed for hydroxylation)
Mnemonic: "NAMANYA has 4 levels of Structure = Primary-Secondary-Tertiary-Quaternary = PSTQ"
PHENYLALANINE-TYROSINE METABOLISM
PHENYLALANINE
│ [Phenylalanine hydroxylase (PAH)] + BH4 (tetrahydrobiopterin)
▼
TYROSINE
│
├──→ [Tyrosine hydroxylase] → DOPA → Dopamine → NE → Epinephrine
│ (CATECHOLAMINES - needs Vit C)
│
├──→ [Tyrosinase] → Melanin (skin pigment)
│ ↓ deficiency = ALBINISM
│
├──→ [Thyroid peroxidase] → Thyroid hormones (T3, T4)
│
└──→ Fumarylacetoacetate → Fumarate + Acetoacetate
[Homogentisate oxidase]
↓ DEFICIENCY
ALKAPTONURIA (accumulates homogentisate)
Clinical Disorders:
| Disease | Enzyme Defect | Accumulates | Features |
|---|
| PKU | Phenylalanine hydroxylase (PAH) | Phenylalanine → phenylpyruvate | Mental retardation, fair skin, musty odor, eczema; Guthrie test |
| Malignant PKU | Dihydrobiopterin reductase (DHPR) - BH4 deficiency | Phe + ↓ neurotransmitters | Worse than PKU, needs BH4 + neurotransmitter precursors |
| Albinism | Tyrosinase | Normal Phe/Tyr levels but no melanin | Hypopigmentation, photosensitivity, nystagmus |
| Alkaptonuria | Homogentisate oxidase | Homogentisic acid | Dark urine on standing, ochronosis (dark cartilage), arthritis |
| Tyrosinemia Type I | Fumarylacetoacetase | Succinylacetone | Liver failure, renal tubular dysfunction, hepatocellular carcinoma |
Mnemonic: "MANIK PKU = Phenylalanine → phenylPYRUVATE → Pee turns phenolic = MUSTY SMELL"
"DIVYA's ALKAP turns black urine - homogentisate oxidase ki kami"
GLYCINE METABOLISM
Glycine = simplest amino acid (only H as side chain)
- Synthesized from serine (reversible; PLP-dependent)
- Conjugated with bile acids → glycocholate, glycochenodeoxycholate
- Precursor: Heme (with succinyl-CoA), Purines, Creatine, Glutathione
- Inhibitory neurotransmitter (spinal cord)
Glycine Cleavage System:
Glycine → CO₂ + NH₃ + methylene-THF (one-carbon unit)
Requires: PLP, Lipoic acid, FAD, NAD⁺, THF
Deficiency → Non-ketotic hyperglycinemia
Clinical: Isoniazid (TB drug) inhibits PLP → deficient glycine/heme metabolism → peripheral neuropathy
SULFUR-CONTAINING AMINO ACID METABOLISM
Methionine Cycle:
METHIONINE + ATP
↓ [Met adenosyltransferase]
S-ADENOSYLMETHIONINE (SAM) ← Universal methyl donor
↓ [Methyltransferase]
S-Adenosylhomocysteine
↓
HOMOCYSTEINE ← Central metabolite
│
├──[Methionine synthase + B12 + Folate]→ METHIONINE (recycled)
│
└──[Cystathionine β-synthase (CBS) + B6]→ Cystathionine → CYSTEINE
Homocystinuria:
| Type | Defect | Features | Treatment |
|---|
| Classic | CBS (B6-dependent) | Marfanoid habitus, lens dislocation (DOWNWARD!), osteoporosis, intellectual disability, thromboembolism | B6 supplementation; if unresponsive: low Met diet + cysteine |
| B12 deficiency | Methionine synthase ↓ | ↑ Homocysteine + megaloblastic anemia | B12 |
| Folate deficiency | Same | Same | Folate |
Marfan vs Homocystinuria:
Marfan = lens UP (superotemporal), AR dominant, normal intelligence
Homocystinuria = lens DOWN (inferonasal), AR recessive, intellectual disability, thrombosis
Mnemonic: "SHUBHAM's HOMOCYST goes DOWN like his CBS enzyme" = Down-displaced lens
MAPLE SYRUP URINE DISEASE (MSUD)
- Defect: Branched-chain α-keto acid dehydrogenase (BCKD)
- Accumulates: Leucine, Isoleucine, Valine and their keto acids
- Features: Sweet maple syrup smell in urine, encephalopathy, cerebral edema, death if untreated
- Treatment: Low BCAA diet; thiamine (B1) supplementation (some responsive forms)
- Mnemonic: "RADHIKA's MAPLE = B1 ki zaroorat + BCAA restrict karo"
SECTION 6: NUCLEOTIDE METABOLISM
PURINE SALVAGE PATHWAY
Why salvage? De novo synthesis is expensive (5-6 ATP per purine). Salvage reuses free purines from catabolism.
HYPOXANTHINE + PRPP →[HGPRT]→ IMP
GUANINE + PRPP →[HGPRT]→ GMP
ADENINE + PRPP →[APRT]→ AMP
PRPP = 5-Phosphoribosyl-1-pyrophosphate (the activated ribose donor)
HGPRT = Hypoxanthine-Guanine Phosphoribosyl Transferase
APRT = Adenine Phosphoribosyl Transferase
SYNTHETIC NUCLEOTIDE ANALOGUES - Short Note
| Drug | Analogue of | Mechanism | Clinical Use |
|---|
| Methotrexate (MTX) | Folate | Inhibits DHFR → ↓ THF → ↓ purine/dTMP synthesis | Cancer, RA, psoriasis |
| 5-Fluorouracil (5-FU) | Uracil | Inhibits thymidylate synthase → ↓ dTMP | Colorectal cancer |
| 6-Mercaptopurine (6-MP) | Hypoxanthine | Inhibits de novo purine synthesis; incorporated into DNA | Leukemia |
| Azathioprine | Prodrug of 6-MP | Same as 6-MP | Immunosuppression |
| Acyclovir | Guanosine | Inhibits viral DNA polymerase | HSV, VZV |
| Zidovudine (AZT) | Thymidine | Inhibits HIV reverse transcriptase | HIV/AIDS |
| Hydroxyurea | - | Inhibits ribonucleotide reductase → ↓ dNTP pool | Sickle cell, CML |
Mnemonic: "MANIK MAKES AMAZING ANTIMETABOLITES = MTX, 5-FU, 6-MP, AZT, Acyclovir"
CLINICAL: GOUT
Pathophysiology:
↑ Uric acid (final product of purine catabolism in humans)
↓
Monosodium urate crystals deposit in joints
↓
Neutrophil phagocytosis → Inflammatory cascade
↓
Acute gout arthritis (podagra = great toe most common)
Causes of Hyperuricemia:
- ↑ Production: High purine diet, HGPRT deficiency (Lesch-Nyhan), G6PD def, psoriasis, myeloproliferative
- ↓ Excretion: Renal insufficiency, thiazides, low-dose aspirin, cyclosporine, alcohol
Treatment:
- Acute: Colchicine (inhibits microtubule polymerization → neutrophil migration blocked), NSAIDs, Corticosteroids
- Chronic: Allopurinol (xanthine oxidase inhibitor, structural analogue of hypoxanthine), Febuxostat, Uricosurics (Probenecid)
Crystal types:
- Gout = Needle-shaped, NEGATIVELY birefringent, yellow under parallel polarized light
- Pseudogout = Rhomboid, positively birefringent (calcium pyrophosphate)
Mnemonic: "NAMANYA's NEEDLE in toe = Negative birefringent = Gout"
LESCH-NYHAN SYNDROME
- Defect: HGPRT deficiency (X-linked recessive) → purines cannot be salvaged → ↑ uric acid
- Features: Gout + Self-mutilation (lip/finger biting - pathognomonic!) + Choreoathetosis + Intellectual disability + Spastic cerebral palsy
- Treatment: Allopurinol for uric acid; NO treatment for neurological features
- Mnemonic: "RADHIKA bites herself = HGPRT gone = Lesch-Nyhan"
OROTIC ACIDURIA
- Defect: UMP synthase (bifunctional: includes orotate phosphoribosyltransferase + orotidine decarboxylase)
- Features: Orotic acid in urine, megaloblastic anemia NOT responding to B12/folate, failure to thrive
- Treatment: Uridine supplementation (bypasses block)
- Distinguish from OTC deficiency: OTC def also has orotic aciduria BUT has hyperammonemia; orotic aciduria has NO hyperammonemia
Mnemonic: "DIVYA's OROTIC = No ammonia, Uridine treats it"
SEVERE COMBINED IMMUNODEFICIENCY (SCID)
- ADA deficiency: Adenosine deaminase deficiency → dATP accumulates → inhibits ribonucleotide reductase → ↓ dNTPs → lymphocyte death (T+B cell deficiency)
- PNP deficiency: Purine nucleoside phosphorylase → dGTP accumulates → mainly T-cell deficiency
Mnemonic: "SHUBHAM's ADA gone = dATP poisons lymphocytes = SCID"
SECTION 7: GENETICS
DNA REPLICATION (LAQ)
Type: Semi-conservative (each strand serves as template)
Direction: 5' → 3' (new strand synthesis)
Key Enzymes:
| Enzyme | Function |
|---|
| Helicase | Unwinds double helix (breaks H-bonds) |
| Topoisomerase I | Relieves torsional stress (nicks 1 strand) |
| Topoisomerase II (Gyrase) | Relieves positive supercoiling (target of fluoroquinolones) |
| Primase | Synthesizes RNA primer (5'→3') |
| DNA Polymerase α | Eukaryotic; synthesizes primers + initial strand (primase activity) |
| DNA Polymerase δ/ε | Main replication enzymes (lagging/leading strand) |
| DNA Polymerase III | PROKARYOTIC main enzyme (holoenzyme) |
| DNA Pol I | Removes RNA primers, fills gaps |
| DNA Ligase | Joins Okazaki fragments (seals nicks) |
| SSB proteins | Stabilize single-stranded DNA |
Replication Steps:
1. ORIGIN of Replication (ORI) recognized by ORC (origin recognition complex)
2. Helicase → opens double helix → REPLICATION FORK
3. Primase → lays RNA primer
4. Leading strand: continuous synthesis 5'→3' toward fork
5. Lagging strand: discontinuous (Okazaki fragments, ~200 bp in eukaryotes)
6. DNA Pol I removes RNA primers, fills gaps
7. Ligase joins fragments
8. Telomerase extends 3' ends of chromosomes
Mnemonic: "MANIK's HAPPY TIP: Helicase, Primase, Topoisomerase for DNA Replication"
TRANSCRIPTION (LAQ)
Product: mRNA, tRNA, rRNA
Direction: 5' → 3'
Template strand: 3' → 5' (antisense/template strand)
Coding strand: 5' → 3' = same sequence as mRNA (sense strand, replaces T with U)
Key Enzymes:
| Enzyme | Prokaryotes | Eukaryotes |
|---|
| RNA Pol core | RNA Pol (α₂ββ'ω) | RNA Pol I (rRNA), II (mRNA), III (tRNA, 5S, snRNA) |
| Promoter | -10 (TATAAT) and -35 (TTGACA) - Pribnow box | TATA box (-25), CAAT box (-75), GC box |
| Sigma factor | Needed (σ factor, reads promoter) | General transcription factors (TFIID, TFIIB, etc.) |
| Start codon | AUG (formyl-Met) | AUG (Met) |
Post-Transcriptional Modifications (eukaryotes):
Pre-mRNA
↓ 5' 7-methylguanosine CAP added
↓ 3' Poly-A tail added (by poly-A polymerase, ~200 A's)
↓ SPLICING: Introns removed, Exons joined
(spliceosome = snRNPs: U1,U2,U4,U5,U6)
↓
Mature mRNA → exported to cytoplasm
Functions:
- 5' Cap: Ribosome binding, protection from exonucleases
- Poly-A tail: mRNA stability, export, translation initiation
- Splicing: exon shuffling, alternative splicing → protein diversity
Mnemonic: "RADHIKA CAPS her mRNA = CAP + Poly-A + Splicing = 3 post-transcriptional mods"
PROTEIN BIOSYNTHESIS - TRANSLATION (LAQ)
Genetic Code Rules:
- Triplet, non-overlapping, universal (mostly), degenerate (multiple codons for 1 AA), unambiguous (1 codon = 1 AA only)
- Start codon: AUG (Met)
- Stop codons: UAA, UAG, UGA ("U Are Away", "U Are Gone", "U Go Away")
Components of Translation:
mRNA - Template (read 5'→3')
tRNA - Adapter (anticodon pairs with codon; carries AA)
- Aminoacyl-tRNA synthetase charges tRNA (uses ATP)
- Wobble position: 3rd base of codon can wobble
Ribosome - 70S (prokaryote) = 30S + 50S
- 80S (eukaryote) = 40S + 60S
- A site: aminoacyl-tRNA entry
- P site: peptidyl-tRNA (growing chain)
- E site: exit (empty tRNA leaves)
Steps:
INITIATION:
40S + mRNA + Met-tRNA + eIF → 80S complex at AUG
ELONGATION (cycle repeats):
1. Aminoacyl-tRNA enters A site (EF-Tu + GTP in prokaryotes)
2. Peptide bond formed (peptidyl transferase activity of 23S/28S rRNA)
3. Translocation: ribosome moves 3' by 1 codon (EF-G + GTP)
TERMINATION:
Stop codon (UAA/UAG/UGA) enters A site
Release factors (RF1/2 in prokaryotes; eRF1 in eukaryotes) → polypeptide released
Post-Translational Modifications:
- Removal of signal peptide
- Glycosylation (N-linked in ER; O-linked in Golgi)
- Phosphorylation (Ser, Thr, Tyr - signaling)
- Hydroxylation (Pro, Lys in collagen - needs Vit C!)
- Acetylation (N-terminus)
- Ubiquitination (proteasomal degradation)
Mnemonic: "DIVYA GOES HAPPILY = N-Glycosylation in ER, O-glycosylation in Golgi"
REGULATION OF GENE EXPRESSION IN EUKARYOTES (Trending!)
Levels of Regulation:
1. EPIGENETIC
- DNA methylation (CpG islands) → gene silencing
- Histone acetylation → chromatin relaxation → gene activation
- Histone methylation → chromatin condensation → gene silencing
- MicroRNA (miRNA) → post-transcriptional silencing
2. TRANSCRIPTIONAL
- Transcription factors bind enhancers/silencers
- Enhancers can be thousands of bp away (looping!)
- Mediator complex bridges TF and RNA Pol II
- Steroid hormones → nuclear receptor → direct TF
- Example: NF-κB, AP-1, p53 (tumor suppressor → activates repair genes)
3. POST-TRANSCRIPTIONAL
- Alternative splicing (1 gene → multiple proteins; e.g., Dscam = 38,000 variants!)
- RNA editing (ApoB: 4536 AA in liver; 2152 AA in intestine - C→U editing)
- 5' cap and 3' Poly-A tail stability
- miRNA/siRNA: binds 3'UTR of mRNA → degradation or translational block
4. TRANSLATIONAL
- eIF-2 phosphorylation → global translation arrest (stress response)
- Iron response element (IRE) - ferritin/transferrin receptor regulation
5. POST-TRANSLATIONAL
- Phosphorylation, ubiquitination, proteolytic cleavage
Mnemonic: "SHUBHAM's EUKARYOTE = ETPPP = Epigenetic, Transcriptional, Post-transcriptional, Translational, Post-translational"
DNA REPAIR MECHANISMS (Trending!)
| Mechanism | Repairs | Key Enzymes | Disease if Defective |
|---|
| Nucleotide Excision Repair (NER) | Bulky lesions (UV-induced pyrimidine dimers) | XPC, TFIIH helicase, endonucleases, Pol δ, Ligase | Xeroderma Pigmentosum (XP) - UV sensitivity, skin cancer |
| Base Excision Repair (BER) | Single damaged bases (deamination, oxidation - 8-oxoG) | DNA glycosylase, AP endonuclease, Pol β, Ligase | - |
| Mismatch Repair (MMR) | Replication errors (insertion/deletion loops) | MSH2, MLH1 (MutS, MutL) | Lynch syndrome (HNPCC) - colorectal cancer |
| Homologous Recombination (HR) | Double-strand breaks | BRCA1, BRCA2, RAD51 | Breast/Ovarian cancer (BRCA1/2 mutations) |
| Non-Homologous End Joining (NHEJ) | Double-strand breaks (any phase) | Ku70/80, DNA-PKcs, Ligase IV | - |
| Direct repair | O⁶-methylguanine | O⁶-methylguanine-DNA methyltransferase (MGMT) | - |
Mnemonic: "NAMANYA NEVER BRINGS HOME DAMAGED MATERIAL"
NER=Never, BER=Brings, HR=Home, NHEJ=Damaged, MMR=Material
TELOMERES & TELOMERASE - Short Note
- Telomeres: Repetitive DNA sequences (TTAGGG repeats in humans) + protective proteins (Shelterin complex) at chromosome ends
- Problem: DNA polymerase cannot replicate very ends of chromosomes → end replication problem → chromosomes shorten with each division
- Solution: TELOMERASE - reverse transcriptase enzyme with its own RNA template (AAUCCC)
- Extends 3' ends of chromosomes
- Active in: Stem cells, germ cells, most cancer cells
- Absent/low in: Somatic cells → aging, senescence
Cancer connection: Telomerase is REACTIVATED in 85-90% of human cancers → immortality
Mnemonic: "MANIK's TTAGGG = Telomere keeps chromosome safe"
INHIBITORS OF PROTEIN SYNTHESIS (Short Note)
| Drug | Target | Effect | Mnemonic |
|---|
| Streptomycin | 30S (prokaryote) | Misreading of mRNA | "30S = SMALL" |
| Tetracycline | 30S (prokaryote) | Blocks aminoacyl-tRNA entry to A site | |
| Chloramphenicol | 50S (prokaryote) | Inhibits peptidyl transferase | Aplastic anemia! |
| Erythromycin | 50S (prokaryote) | Blocks translocation | |
| Linezolid | 50S (prokaryote) | Blocks initiation | |
| Cycloheximide | 60S (eukaryote) | Inhibits translocation | Research only |
| Diphtheria toxin | EF-2 (eukaryote) | ADP-ribosylation → blocks translocation | |
| Ricin (from castor) | 60S rRNA | Depurinates 28S rRNA | |
| Puromycin | Both | Premature chain termination | |
"30S inhibitors = SCAT" = Streptomycin, Chloramphenicol (actually 50S), Aminoglycosides, Tetracycline
Better: "BIG MAC inhibits 50S" = B=Bleomycin, M=Macrolides, A=clindAmycin, C=Chloramphenicol, L=Linezolid
PCR (Polymerase Chain Reaction) - Short Note
Purpose: Amplify specific DNA sequences in vitro
Steps (cycle of 3 temperatures):
STEP 1: DENATURATION (94-96°C) → Separate double-stranded DNA
STEP 2: ANNEALING (50-65°C) → Primers bind to target sequences
STEP 3: EXTENSION (72°C) → Taq polymerase extends from primers
After n cycles → 2ⁿ copies of target DNA
30 cycles → ~10⁹ copies
Key components: Template DNA, Primers (short synthetic oligonucleotides), Taq polymerase (thermostable), dNTPs, Mg²⁺, buffer
Clinical uses: Diagnosis of infections (TB, HIV), genetic diseases, forensics (DNA fingerprinting), paternity testing, cancer mutations
DNA FINGERPRINTING - Short Note
Basis: VNTRs (Variable Number Tandem Repeats) and STRs (Short Tandem Repeats) are unique to each individual
Method:
- Extract DNA
- PCR amplify STR loci (or RFLP analysis with restriction enzymes)
- Gel electrophoresis → banding pattern
- Southern blot / DNA profiling
Uses: Forensics, paternity testing, criminal investigation, disaster victim identification
RECOMBINANT DNA TECHNOLOGY - Short Note
KEY TOOLS:
1. Restriction endonucleases → cut DNA at specific sequences (sticky/blunt ends)
2. Ligase → join DNA fragments
3. Vectors (plasmids, bacteriophage, BAC) → carry foreign DNA
4. Host cells (E. coli, yeast) → express recombinant protein
STEPS:
Gene of interest → cut with RE → insert into vector → transform into host →
select recombinants → culture → harvest recombinant protein
APPLICATIONS:
- Insulin production (recombinant human insulin)
- HBV vaccine (recombinant HBsAg)
- Erythropoietin (EPO)
- Tissue plasminogen activator (tPA)
- Growth hormone
- Southern blot (DNA), Northern blot (RNA), Western blot (protein)
Mnemonic: "RADHIKA's DNA KITCHEN: RE cuts, Ligase joins, Vector carries, Host cooks the protein"
SECTION 8: MISCELLANEOUS TOPICS
KIDNEY FUNCTION TESTS (KFT)
| Test | Normal Value | Measures | Significance |
|---|
| Serum Creatinine | 0.6-1.2 mg/dL | GFR (inversely) | Most reliable routine marker |
| BUN (Blood Urea Nitrogen) | 7-20 mg/dL | Urea metabolism + GFR | BUN:Creatinine >20:1 = prerenal; <10:1 = postrenal |
| GFR | >90 mL/min/1.73m² | Gold standard of kidney function | CKD stages based on GFR |
| Creatinine clearance | 95-135 mL/min | Approximate GFR | 24h urine + serum Cr |
| Inulin clearance | = GFR | Gold standard (not metabolized) | Research use |
| eGFR (CKD-EPI) | Calculated | Routine clinical use | - |
| Urine osmolality | 50-1200 mOsm/kg | Concentrating ability | ↓ in DI, renal disease |
| Uric acid | 2.5-7.0 mg/dL | Purine metabolism + renal excretion | ↑ in gout, renal failure |
CKD Staging (GFR):
- Stage 1: ≥90 (kidney damage, normal GFR)
- Stage 2: 60-89 (mild)
- Stage 3: 30-59 (moderate) - uremia symptoms
- Stage 4: 15-29 (severe)
- Stage 5: <15 (ESRD - dialysis needed)
Mnemonic: "MANIK's CREATININE never lies about kidney"
LIVER FUNCTION TESTS (LFT)
| Test | Normal | Significance |
|---|
| ALT (SGPT) | 7-56 U/L | Hepatocellular damage (most specific for liver) |
| AST (SGOT) | 10-40 U/L | Hepatocellular damage (also heart, muscle) |
| ALP | 44-147 U/L | Cholestasis, infiltrative disease, bone disease |
| GGT | <55 U/L | Sensitive marker cholestasis + alcoholism |
| Bilirubin (total) | 0.2-1.2 mg/dL | Hemolysis, hepatic, cholestatic jaundice |
| Direct (conjugated) | <0.3 mg/dL | ↑ = hepatic or post-hepatic jaundice |
| Indirect (unconjugated) | <0.8 mg/dL | ↑ = hemolytic or pre-hepatic jaundice |
| Albumin | 3.5-5.0 g/dL | Synthetic function (↓ = chronic liver disease) |
| PT/INR | 11-14s / 1.0 | Clotting factors (all except Factor VIII made in liver) |
| LDH | 100-250 U/L | Non-specific but ↑ liver/hemolysis |
ALT:AST ratio:
- ALT>AST = Viral hepatitis
- AST:ALT >2:1 = Alcoholic hepatitis
Mnemonic: "RADHIKA: ALCOHOL = AST > ALT = A first (AST > ALT ratio)"
THYROID FUNCTION TESTS (TFT)
| Test | Normal | Hypothyroid | Hyperthyroid |
|---|
| TSH | 0.4-4.0 mIU/L | ↑ (primary) | ↓ |
| Free T4 | 0.8-1.8 ng/dL | ↓ | ↑ |
| Free T3 | 2.3-4.2 pg/mL | ↓ | ↑ |
| T3 resin uptake | - | ↓ | ↑ |
| Anti-TPO antibody | Negative | ↑ Hashimoto's | ↑ Graves (sometimes) |
| Anti-TSH receptor | Negative | - | ↑ Graves disease |
| TBG (Thyroxine Binding Globulin) | - | ↑ Pregnancy, OCP | ↓ Nephrotic, androgens |
Key biochemistry:
T4 → T3 conversion: peripheral deiodinase (5'-deiodinase), inhibited by propylthiouracil (PTU)
T3 is 3-4x more active than T4
Mnemonic: "TSH is BOSS - LOW TSH = hyperthyroid (boss is suppressed)"
ACID-BASE BALANCE & DISORDERS
Henderson-Hasselbalch:
pH = 6.1 + log [HCO₃⁻] / (0.03 × PaCO₂)
Normal: pH 7.35-7.45, HCO₃⁻ 22-26 mEq/L, PaCO₂ 35-45 mmHg
Four Primary Disorders:
| Disorder | pH | Primary Change | Compensation |
|---|
| Metabolic acidosis | ↓ | ↓ HCO₃⁻ | ↓ PaCO₂ (Kussmaul breathing) |
| Metabolic alkalosis | ↑ | ↑ HCO₃⁻ | ↑ PaCO₂ (hypoventilation) |
| Respiratory acidosis | ↓ | ↑ PaCO₂ | ↑ HCO₃⁻ (renal retention) |
| Respiratory alkalosis | ↑ | ↓ PaCO₂ | ↓ HCO₃⁻ (renal excretion) |
Anion Gap (AG):
AG = Na⁺ - (Cl⁻ + HCO₃⁻) Normal = 8-12 mEq/L
HIGH AG metabolic acidosis (MUDPILES):
M - Methanol
U - Uremia (renal failure)
D - DKA (diabetic ketoacidosis)
P - Propylene glycol / Paraldehyde
I - Isoniazid / Iron
L - Lactic acidosis
E - Ethylene glycol
S - Salicylates
NORMAL AG (hyperchloremic) metabolic acidosis:
- Diarrhea (HCO₃⁻ loss)
- RTA (Renal Tubular Acidosis)
- Saline infusion
Mnemonic: "NAMANYA MUDPILES se acidotic ho gayi" = MUDPILES causes high AG metabolic acidosis
BIOTRANSFORMATION (XENOBIOTICS)
Definition: Chemical modification of foreign compounds (drugs, toxins, pollutants) in the body to make them water-soluble for excretion
Site: Primarily LIVER (smooth ER, cytoplasm), also intestine, lung, kidney
Two Phases:
PHASE I - Functionalization (introduce or expose functional groups: -OH, -COOH, -NH₂, -SH)
- Oxidation (most common): CYP450 system (NADPH, O₂ dependent)
- CYP3A4 = metabolizes ~50% of drugs!
- Reduction, Hydrolysis
- Products may be MORE or LESS toxic
PHASE II - Conjugation (add large polar groups to Phase I products)
| Conjugation | Donor | Enzyme |
|---|
| Glucuronidation | UDP-Glucuronate | UDP-Glucuronosyltransferase (UGT) - MOST COMMON |
| Sulfation | PAPS | Sulfotransferase |
| Methylation | SAM | Methyltransferase |
| Acetylation | Acetyl-CoA | N-Acetyltransferase (NAT) - slow vs fast acetylators! |
| Glutathione conjugation | Glutathione | GST - protects against reactive intermediates |
CYP450 Inducers: Rifampicin, Phenobarbital, Carbamazepine, St. John's Wort, Alcohol (chronic) → ↓ drug levels
CYP450 Inhibitors: Ketoconazole, Erythromycin, Cimetidine, Grapefruit juice → ↑ drug toxicity
Mnemonic: "RADHIKA PICKS" = Rifampicin, Phenobarb, Induces CYP450 = King's Speed up
FREE RADICALS
Definition: Atoms/molecules with unpaired electrons; highly reactive
| Radical | Source | Harmful Effect |
|---|
| Superoxide (O₂•⁻) | ETC, activated neutrophils | Lipid peroxidation |
| Hydroxyl radical (•OH) | Fenton reaction (Fe²⁺ + H₂O₂) | Most dangerous! DNA damage |
| Nitric oxide (NO•) | NOS in endothelium | Signal + ONOO⁻ (peroxynitrite) |
| Lipid peroxyl radicals | FA oxidation | Membrane damage |
Antioxidant Defense:
| Antioxidant | Action |
|---|
| Superoxide dismutase (SOD) | O₂•⁻ → H₂O₂ + O₂ (Mn-SOD in mito, Cu-Zn-SOD in cytoplasm) |
| Catalase | H₂O₂ → H₂O + O₂ (in peroxisomes) |
| Glutathione peroxidase | H₂O₂ + 2GSH → 2H₂O + GSSG (needs NADPH/G6PD!) |
| Glutathione reductase | GSSG + NADPH → 2GSH |
| Vitamin E (α-tocopherol) | Lipid-soluble; interrupts lipid peroxidation chain |
| Vitamin C (Ascorbic acid) | Aqueous-phase scavenger; regenerates Vit E |
| β-Carotene | Quenches singlet oxygen in lipid phase |
| Uric acid | Antioxidant in plasma |
G6PD deficiency → ↓ NADPH → ↓ reduced glutathione → RBCs vulnerable to oxidative stress → hemolysis
Mnemonic: "SHUBHAM's CAGE defense: CAtalase, Glutathione peroxidase, E-vitamin, SOD"
CANCER BIOCHEMISTRY
Molecular Basis:
PROTO-ONCOGENES (normal growth promoters)
↓ mutation/amplification/translocation
ONCOGENES (constitutively active growth signals)
TUMOR SUPPRESSOR GENES (growth brakes)
↓ BOTH copies mutated (Knudson's two-hit hypothesis)
CANCER
Key Examples:
| Gene | Type | Cancer | Mechanism |
|---|
| RAS | Proto-oncogene (GTPase) | Pancreas, colon, lung | Constitutive GTP binding |
| MYC | Proto-oncogene (TF) | Burkitt lymphoma (t(8;14)) | Uncontrolled proliferation |
| BCL-ABL | Fusion oncogene | CML (t(9;22) Philadelphia) | Constitutive tyrosine kinase |
| HER2/neu | Proto-oncogene | Breast cancer | Receptor overexpression |
| p53 | Tumor suppressor | >50% human cancers | ↓ apoptosis, ↓ DNA repair |
| RB | Tumor suppressor | Retinoblastoma | ↓ cell cycle arrest |
| BRCA1/2 | Tumor suppressor | Breast/ovarian | ↓ DNA repair |
| APC | Tumor suppressor | Colorectal | ↓ WNT pathway braking |
Mnemonic: "MANIK's CANCER = RAS MYC p53 = 3 most important oncogenes/suppressors"
Tumor Markers:
| Marker | Cancer |
|---|
| AFP (alpha-fetoprotein) | HCC, testicular germ cell |
| CEA | Colorectal, gastric, lung |
| PSA | Prostate |
| CA-125 | Ovarian |
| CA 19-9 | Pancreatic |
| β-hCG | Choriocarcinoma, gestational trophoblastic |
| LDH | Lymphoma, testicular |
| Bence-Jones protein | Multiple myeloma |
HEMOGLOBIN, HEME SYNTHESIS, BILIRUBIN METABOLISM & JAUNDICE
HEME SYNTHESIS:
MITOCHONDRIA:
Succinyl-CoA + Glycine
↓ [ALA synthase] ← RATE-LIMITING STEP (needs PLP/B6)
↓ Inhibited by HEME (feedback inhibition)
δ-ALA (aminolevulinic acid)
↓ (to CYTOPLASM)
CYTOPLASM:
2 δ-ALA
↓ [ALA dehydratase] ← inhibited by LEAD (Pb)!
Porphobilinogen (PBG)
↓ [PBG deaminase] ← deficient in ACUTE INTERMITTENT PORPHYRIA (AIP)
Hydroxymethylbilane
↓ [Uroporphyrinogen III synthase]
Uroporphyrinogen III
↓ [Uroporphyrinogen decarboxylase] ← deficient in PORPHYRIA CUTANEA TARDA (PCT)
Coproporphyrinogen III
↓ (to MITOCHONDRIA)
MITOCHONDRIA:
Coproporphyrinogen III
↓
Protoporphyrinogen IX
↓ [Protoporphyrinogen oxidase]
Protoporphyrin IX
↓ [Ferrochelatase] ← inhibited by LEAD!
+ Fe²⁺
HEME
PORPHYRIAS (Exam Favourite!):
| Disease | Deficient Enzyme | Accumulates | Features | Type |
|---|
| AIP (Acute Intermittent Porphyria) | PBG deaminase | ALA + PBG | Acute attacks: abdominal pain, neuropsychiatric, NO skin lesions; ↑ urine ALA+PBG | Acute (hepatic) |
| Porphyria Cutanea Tarda (PCT) | Uroporphyrinogen decarboxylase | Uroporphyrin | Skin photosensitivity, NO acute attacks; ↑ urine uroporphyrin | Chronic (hepatic) |
| Congenital Erythropoietic Porphyria | Uroporphyrinogen III synthase | Uroporphyrin I | Severe photosensitivity, hemolytic anemia, red teeth/urine | Erythropoietic |
| Lead poisoning | ALA dehydratase + Ferrochelatase | ALA + protoporphyrin | Basophilic stippling, neurological, ↑ urine ALA, NO PBG | Toxic |
AIP mnemonic: "NAMANYA has AIP = 5 P's: Pain (abdomen), Psychological, Peripheral neuropathy, Port-wine urine, Precipitated by fasting/drugs"
BILIRUBIN METABOLISM:
RBC lysis (after 120 days) in RES (spleen, liver)
↓
HEMOGLOBIN
↓ [Heme oxygenase] - breaks heme ring
BILIVERDIN + CO + Fe²⁺
↓ [Biliverdin reductase]
UNCONJUGATED BILIRUBIN (indirect)
= Water-INSOLUBLE, lipid-soluble, TOXIC (crosses BBB!)
= Transported in blood BOUND TO ALBUMIN
↓ → LIVER
Taken up by hepatocytes (carrier-mediated)
↓ [UDP-Glucuronosyltransferase (UGT1A1)]
+ 2 UDP-Glucuronate
CONJUGATED BILIRUBIN (direct bilirubin) = Bilirubin diglucuronide
= Water-SOLUBLE, NON-toxic, excreted in BILE
↓ → Bile → Intestine
UROBILINOGEN (by gut bacteria)
↓
├── Excreted in STOOL as STERCOBILIN (brown color of stool)
└── Reabsorbed, goes to kidney → UROBILIN (yellow color of urine)
JAUNDICE - TYPES:
| Feature | Pre-hepatic (Hemolytic) | Hepatic | Post-hepatic (Obstructive) |
|---|
| Cause | Excess RBC destruction | Liver cell damage | Bile duct obstruction |
| Serum bilirubin | ↑ Indirect (unconjugated) | Both ↑ | ↑ Direct (conjugated) |
| Urine bilirubin | ABSENT (not water-soluble) | Present | Present (dark urine) |
| Urine urobilinogen | ↑↑ (more bilirubin → more UBG) | ↑ or normal | ABSENT (no bile reaches gut) |
| Stool color | Normal/dark | Pale | PALE (clay-colored) |
| Pruritus | No | Sometimes | YES (bile salts) |
| LFT | AST/ALT normal; ↑ LDH | ↑ AST/ALT | ↑ ALP, GGT |
| Examples | Hemolysis, G6PD, thalassemia | Viral hepatitis, cirrhosis | Gallstones, cancer head of pancreas, cholangiocarcinoma |
Mnemonic: "DIVYA's JAUNDICE types: Pre-hepatic = Pee pale + stool dark; Obstructive = Pee dark + stool pale"
Neonatal Jaundice:
- Physiological: UGT1A1 immature; peaks day 3-4; unconjugated; treated with phototherapy
- Pathological: Before day 1 (hemolytic), or direct hyperbilirubinemia
- Crigler-Najjar Type I: No UGT1A1 → fatal; exchange transfusion/phototherapy/liver transplant
- Crigler-Najjar Type II: ↓ UGT1A1 → phenobarb induces UGT → treatable
- Gilbert syndrome: Mild ↓ UGT1A1 (benign, stress/fasting precipitates); unconjugated; no treatment
- Dubin-Johnson: Defective conjugated bilirubin transport out of hepatocyte → direct; BLACK liver
Mnemonic: "SHUBHAM's CRIGLER can't CONJUGATE - Type I die, Type II survive with Phenobarb"
QUICK-FIRE CLINICAL SUMMARY TABLE
| Disease | Enzyme Defect | Inheritance | Key Feature |
|---|
| PKU | Phenylalanine hydroxylase | AR | Musty odor, fair skin |
| Alkaptonuria | Homogentisate oxidase | AR | Dark urine, ochronosis |
| Homocystinuria | CBS | AR | Lens DOWN, thrombosis, Marfanoid |
| MSUD | BCKD | AR | Maple syrup smell, BCAA ↑ |
| Galactosemia | Galactose-1-P uridyltransferase | AR | Cataracts + liver failure + E. coli sepsis |
| Lactose intolerance | Lactase deficiency | - | Bloating, diarrhea after milk |
| G6PD deficiency | G6PD | X-linked | Hemolysis with oxidant stress |
| Gaucher | β-Glucocerebrosidase | AR | Crumpled paper macrophages |
| Tay-Sachs | Hexosaminidase A | AR | Cherry red spot, no hepatosplenomegaly |
| Niemann-Pick | Sphingomyelinase | AR | Cherry red spot + hepatosplenomegaly |
| Fabry | α-Galactosidase A | X-linked | Angiokeratomas, renal failure |
| Von Gierke | Glucose-6-phosphatase | AR | Severe fasting hypoglycemia, hepatomegaly |
| McArdle | Muscle phosphorylase | AR | Exercise cramps, no lactate rise |
| Lesch-Nyhan | HGPRT | X-linked | Self-mutilation, gout |
| AIP | PBG deaminase | AD | Acute abdominal pain, no skin |
| Xeroderma pigmentosum | NER enzymes (XPC etc.) | AR | UV sensitivity, early skin cancers |
| Krabbe | Galactocerebrosidase | AR | Globoid cells, neuropathy |
MASTER HINDI MNEMONIC TEAM
"MANIK, RISHIKA, NAMANYA, DIVYA, SHUBHAM, RADHIKA" - Each owns a subject!
| Person | Their Topic | Their Mnemonic |
|---|
| MANIK | Membrane transport + Metabolic regulation | "MANIK manages MEMBRANE and METABOLISM" |
| RISHIKA | Regulation of blood glucose | "RISHIKA REGULATES glucose - INSULIN + GLUCAGON" |
| NAMANYA | Nucleotide metabolism + DNA repair | "NAMANYA NEVER breaks DNA - she REPAIRS it" |
| DIVYA | DKA + Diabetic ketoacidosis | "DIVYA's DKA = FLUIDS + INSULIN + KCl" |
| SHUBHAM | Synthase enzymes + Synthesis pathways | "SHUBHAM SYNTHESIZES - FA, Cholesterol, Glycogen" |
| RADHIKA | Replication + Repair + Reverse transport | "RADHIKA REPLICATES DNA faithfully" |
Sources: Lippincott's Illustrated Biochemistry 8th Ed; Basic Medical Biochemistry (Lieberman) 6th Ed; Harper's Illustrated Biochemistry 32nd Ed; Ganong's Review of Medical Physiology 26th Ed; Henry's Clinical Diagnosis by Laboratory Methods; Tietz Textbook of Laboratory Medicine 7th Ed
Now let me create this as a downloadable PDF document: